The Subject Expert Committee under the CDSCO (Central Drug Standard Organization) has directed the Akums Drugs and Pharmaceuticals to revise the phase 3 clinical trial protocol for abortion drug Mifepristone Tablets 10/25mg.
In the 58th SEC meeting held on 25.02.2021 firm presented Phase 3 Clinical Trial protocol for Mifepristone Tablets 10/25mg.
The drug Mifepristone is a steroidal anti-progestin drug that is used to induce abortion and functions as a competitive progesterone receptor antagonist in the presence of progesterone. It causes the pregnancy to end by blocking the hormone progesterone, which is to keep the pregnancy going.
Moving to the launch of the said drug the clinical trial and the Bioequivalence Study waiver was presented by Akums Drugs and Pharmaceuticals for granting permission to manufacture Mifepristone Tablet 10mg & 25mg at the 50th Subject Expert Committee meeting held last year. Responding to this the committee recommended that the firm should conduct a clinical trial to examine the efficacy and safety of the drug in the proposed indication and said that the firm submit the clinical trial protocol for further review.
Committee reviewed the clinical trial protocol in its recent meeting and after a detailed deliberation, the committee recommended the firm to revise the clinical trial protocol according to below conditions:
The committee added that the firm should submit the revised protocol before the committee for further consideration.
Antibiotic use has surged globally, leading to a rise in antibiotic resistance, especially concerning in…
Choking is a leading cause of injury and death in young children, particularly those under…
Hard Water (Khara Pani) Leading To Hair Fall Hard water is rich in minerals and…
Discover how the rise in high blood pressure during pregnancy is impacting maternal and fetal…
"Discover the transformative power of six delicious homemade drinks that can help you naturally melt…
"Transform your weight loss routine with these eight delicious fat-flushing drinks that not only hydrate…